These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24368769)

  • 1. Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells.
    Moulton VR; Gillooly AR; Tsokos GC
    J Biol Chem; 2014 Feb; 289(7):4126-34. PubMed ID: 24368769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.
    Moulton VR; Gillooly AR; Perl MA; Markopoulou A; Tsokos GC
    PLoS One; 2015; 10(7):e0131073. PubMed ID: 26134847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1.
    Kono M; Kurita T; Yasuda S; Kono M; Fujieda Y; Bohgaki T; Katsuyama T; Tsokos GC; Moulton VR; Atsumi T
    Arthritis Rheumatol; 2018 Dec; 70(12):2046-2056. PubMed ID: 29905030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-Induced hsa-miR-10b-5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down-Regulates Serine/Arginine-Rich Splicing Factor 1.
    Ramanujan SA; Cravens EN; Krishfield SM; Kyttaris VC; Moulton VR
    Arthritis Rheumatol; 2021 Nov; 73(11):2052-2058. PubMed ID: 33982889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing factor SF2/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription.
    Moulton VR; Grammatikos AP; Fitzgerald LM; Tsokos GC
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1845-50. PubMed ID: 23319613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.
    Moulton VR; Tsokos GC
    J Biol Chem; 2010 Apr; 285(17):12490-6. PubMed ID: 20118245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus.
    Katsuyama T; Martin-Delgado IJ; Krishfield SM; Kyttaris VC; Moulton VR
    Rheumatology (Oxford); 2020 Aug; 59(8):2146-2155. PubMed ID: 32206811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.
    Katsuyama T; Li H; Comte D; Tsokos GC; Moulton VR
    J Clin Invest; 2019 Dec; 129(12):5411-5423. PubMed ID: 31487268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune disease.
    Cassidy MF; Herbert ZT; Moulton VR
    Mol Immunol; 2022 Jan; 141():94-103. PubMed ID: 34839165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3.
    Cassidy MF; Herbert ZT; Moulton VR
    Mol Immunol; 2022 Dec; 152():140-152. PubMed ID: 36368121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
    Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
    J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.
    Rauen T; Benedyk K; Juang YT; Kerkhoff C; Kyttaris VC; Roth J; Tsokos GC; Tenbrock K
    J Biol Chem; 2011 Sep; 286(37):32366-72. PubMed ID: 21757709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B.
    Harigai M; Kawamoto M; Hara M; Kubota T; Kamatani N; Miyasaka N
    J Immunol; 2008 Aug; 181(3):2211-9. PubMed ID: 18641361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients.
    Latini A; Novelli L; Ceccarelli F; Barbati C; Perricone C; De Benedittis G; Conti F; Novelli G; Ciccacci C; Borgiani P
    Lupus; 2021 Jun; 30(7):1086-1093. PubMed ID: 33794704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia.
    Zou L; Zhang H; Du C; Liu X; Zhu S; Zhang W; Li Z; Gao C; Zhao X; Mei M; Bao S; Zheng H
    J Hematol Oncol; 2012 Jul; 5():42. PubMed ID: 22839530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.
    Das S; Krainer AR
    Mol Cancer Res; 2014 Sep; 12(9):1195-204. PubMed ID: 24807918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell activation regulates CD6 alternative splicing by transcription dynamics and SRSF1.
    da Glória VG; Martins de Araújo M; Mafalda Santos A; Leal R; de Almeida SF; Carmo AM; Moreira A
    J Immunol; 2014 Jul; 193(1):391-9. PubMed ID: 24890719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus.
    Jury EC; Flores-Borja F; Kalsi HS; Lazarus M; Isenberg DA; Mauri C; Ehrenstein MR
    Eur J Immunol; 2010 Feb; 40(2):569-78. PubMed ID: 19950182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis.
    Katsuyama T; Li H; Krishfield SM; Kyttaris VC; Moulton VR
    Rheumatology (Oxford); 2021 Jan; 60(1):420-429. PubMed ID: 32810232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A splice variant of the TCR zeta mRNA lacking exon 7 leads to the down-regulation of TCR zeta, the TCR/CD3 complex, and IL-2 production in systemic lupus erythematosus T cells.
    Tsuzaka K; Setoyama Y; Yoshimoto K; Shiraishi K; Suzuki K; Abe T; Takeuchi T
    J Immunol; 2005 Mar; 174(6):3518-25. PubMed ID: 15749888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.